Bispecific antibodies for the treatment in inflammatory bowel disease: an avenue worth exploring? - Université de Lorraine Access content directly
Journal Articles Expert Opinion on Biological Therapy Year : 2022

Bispecific antibodies for the treatment in inflammatory bowel disease: an avenue worth exploring?

Abstract

No abstract available

Dates and versions

hal-04167932 , version 1 (21-07-2023)

Identifiers

Cite

Bénédicte Caron, Patrick Netter, Silvio Danese, Laurent Peyrin‐biroulet. Bispecific antibodies for the treatment in inflammatory bowel disease: an avenue worth exploring?. Expert Opinion on Biological Therapy, 2022, 22 (8), pp.951-953. ⟨10.1080/14712598.2022.1985999⟩. ⟨hal-04167932⟩
28 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More